Literature DB >> 2432721

Ovarian Sertoli-Leydig cell tumour with raised serum alpha fetoprotein. A case report.

A Tiltman, K Dehaeck, R Soeters, G Goldberg, W Levin.   

Abstract

A case of ovarian Sertoli-Leydig cell tumour with a raised serum alpha fetoprotein is reported. The patient first presented at the age of 27 years with a history of 6 years' amenorrhoea followed by 3 months irregular vaginal bleeding. A ovarian tumour was found and excised and shown microscopically to be a spindle cell malignant tumour. The patient was treated with chemotherapy and had a complete response. Thirty months after first presentation there was a recurrence in the pelvis which microscopically showed the typical features of a Sertoli-Leydig cell tumour. Six months later a second recurrence had the microscopic appearance of a lipid cell tumour. A raised serum alpha fetoprotein was found at the time of the second recurrence and immunohistochemistry showed this protein in the Leydig and luteinized cells of the recurrent tumours but not in the spindle cells of the original ovarian neoplasm.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432721     DOI: 10.1007/bf00713513

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  10 in total

1.  HISTOLOGICAL AND HISTOCHEMICAL DATA ON THE PROCESS OF REGRESSION OF EXPERIMENTAL TUMOURS INDUCED BY ALKYLATING AGENTS.

Authors:  M A PRESNOV
Journal:  Acta Unio Int Contra Cancrum       Date:  1964

2.  Androblastoma and raised serum alpha-fetoprotein with familial multinodular goitre. Case report.

Authors:  G F Benfield; L Tapper-Jones; T V Stout
Journal:  Br J Obstet Gynaecol       Date:  1982-04

3.  Sertoli-Leydig cell tumor of the ovary.

Authors:  A Talerman; W G Haije
Journal:  Int J Gynecol Pathol       Date:  1985       Impact factor: 2.762

Review 4.  Ovarian low-grade stromal sarcoma with thecomatous features: a critical reappraisal of the so-called "malignant thecoma".

Authors:  M Waxman; J C Vuletin; R Urcuyo; C G Belling
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

5.  Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III).

Authors:  C Merrin; H Takita; R Weber; Z Wajsman; G Baumgartner; G P Murphy
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

6.  Multiple biochemical markers in patients with gynecologic malignancies.

Authors:  E S Donaldson; J R van Nagell; S Pursell; E C Gay; W R Meeker; R Kashmiri; J van deVoorde
Journal:  Cancer       Date:  1980-03-01       Impact factor: 6.860

7.  Serum alpha-fetoprotein-positive gastric carcinoid with liver metastasis.

Authors:  H Mori; M Onji; A Yoshida; R Fukunishi
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

8.  Ovarian Sertoli-Leydig cell tumors with a retiform pattern: a problem in histopathologic diagnosis. A report of 25 cases.

Authors:  R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1983-12       Impact factor: 6.394

9.  Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein.

Authors:  J C Chumas; Z Rosenwaks; W J Mann; G Finkel; J Pastore
Journal:  Int J Gynecol Pathol       Date:  1984       Impact factor: 2.762

10.  Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.

Authors:  R H Young; A R Perez-Atayde; R E Scully
Journal:  Am J Surg Pathol       Date:  1984-09       Impact factor: 6.394

  10 in total
  2 in total

Review 1.  Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Canas Marques; Ana Félix
Journal:  J Radiol Case Rep       Date:  2014-11-30

2.  15-Year-Old Patient with an Unusual Alpha-Fetoprotein-Producing Sertoli-Leydig Cell Tumor of Ovary.

Authors:  Kaçar Serife; Stavros Karampelas; Nathalie Hottat; Christine Devalck; Katherina Vanden Houte
Journal:  Case Rep Obstet Gynecol       Date:  2022-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.